| Authors: |
Morgan KA; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, 3010 Victoria, Australia., Grieve ML; Australian Institute for Bioengineering and Nanotechnology, the University of Queensland, Brisbane, QLD 4072, Australia.; ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR), the University of Queensland, Brisbane, QLD 4072, Australia., Akhter DT; Australian Institute for Bioengineering and Nanotechnology, the University of Queensland, Brisbane, QLD 4072, Australia.; ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR), the University of Queensland, Brisbane, QLD 4072, Australia., Lange JL; Clarity Pharmaceuticals Ltd., National Innovation Centre, 4 Cornwallis Street, Eveleigh, New South Wales 2042, Australia., Harris MJ; Clarity Pharmaceuticals Ltd., National Innovation Centre, 4 Cornwallis Street, Eveleigh, New South Wales 2042, Australia., Thurecht KJ; Australian Institute for Bioengineering and Nanotechnology, the University of Queensland, Brisbane, QLD 4072, Australia.; ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR), the University of Queensland, Brisbane, QLD 4072, Australia., Paterson BM; Australian Institute for Bioengineering and Nanotechnology, the University of Queensland, Brisbane, QLD 4072, Australia.; ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR), the University of Queensland, Brisbane, QLD 4072, Australia., Donnelly PS; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, 3010 Victoria, Australia. |
